HEALTH● LOWSep 22 · Sep 22, 2026, 1:29 PM
Ionis gains on late-stage trial results for ulefnersen in ALS
Seeking Alpha Tech · global
Ionis Pharmaceuticals has seen gains following positive late-stage trial results for ulefnersen, a drug being developed for ALS. This indicates potential progress in treating the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH31m agoSuspected Fake Surgeon Arrested In Rivers State, Eight Facilities SealedChannels TVHEALTH34m agoMental health at work starts by breaking the taboo, EU agency saysEuroNews [en]HEALTH52m agoUCH resident doctors suspend warning strikeVanguard NigeriaHEALTH54m agoEssential items to stock in your medicine cabinet for cold and flu seasonNPR News